Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
10.3748/wjg.v20.i26.8393 158 TrebergJ
Take daily at the same time for best results
Introduction One recent advance in the management of type 2 diabetes has been the development and clinical use of DPP-4 inhibitors and GLP-1 receptor agonists
Key indicators of this transformation include trends in medtech volumes, such as a decline in bariatric surgeries, shifts in insurers policies and early adoption of oral obesity medications
In diabetic NAFLD populations, Godex treatment for 12 weeks significantly improved liver enzymes (56), and L-carnitine monotherapy for 3 months similarly enhanced hepatic function in type 2 diabetes patients with NAFLD (66)
Regular monitoring of kidney function is essential for anyone taking metformin, as declining renal function necessitates dose adjustment or discontinuation
